Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Co-trimoxazole may help treat autoimmune diseases.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Canakinumab's effect on COVID-19 outcomes is unclear.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Early diagnosis is crucial for treating alopecia effectively.

New cytokine-targeted therapies show promise for treating alopecia areata.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.